Baker Mark Robert 4
4 · PROGENICS PHARMACEUTICALS INC · Filed Nov 30, 2012
Insider Transaction Report
Form 4
Baker Mark Robert
General Counsel
Transactions
- Purchase
Common Stock
2012-11-28$2.12/sh+300$636→ 155,565 total - Purchase
Common Stock
2012-11-28$2.12/sh+100$212→ 155,665 total - Purchase
Common Stock
2012-11-28$2.13/sh+100$213→ 155,865 total - Purchase
Common Stock
2012-11-28$2.13/sh+1,000$2,130→ 156,865 total - Purchase
Common Stock
2012-11-28$2.14/sh+7$15→ 156,872 total - Purchase
Common Stock
2012-11-28$2.13/sh+100$213→ 155,765 total
Footnotes (1)
- [F1]Open market purchase pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.